Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

GM 608 in A Phase IIA Pilot Double-blinded, Randomized, Placebo Controlled Trial in Mild to Moderate Parkinson Disease

NCT01850381 is registered in ClinicalTrials.gov with Genervon Biopharmaceuticals, LLC as lead sponsor.

NCT NCT01850381
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01850381 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
GM 608 in A Phase IIA Pilot Double-blinded, Randomized, Placebo Controlled Trial in Mild to Moderate Parkinson Disease
Lead sponsor
Genervon Biopharmaceuticals, LLC
Phase
Phase 2
Overall status
Completed
Start date
June 30, 2013
Completion date
July 31, 2014
Enrollment
6 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

parkinson's disease